As estratégias de prevenção primária se baseiam na redução dos fatores de risco por meio da modificação do estilo de vida.[1]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024 Jan 2;149(1):e1-156.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001193?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/38033089?tool=bestpractice.com
[2]Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021 Feb 1;42(5):373-498.
https://academic.oup.com/eurheartj/article/42/5/373/5899003
http://www.ncbi.nlm.nih.gov/pubmed/32860505?tool=bestpractice.com
[3]Lévy S, Steinbeck G, Santini L, et al. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol. 2022 Oct;65(1):287-326.
http://www.ncbi.nlm.nih.gov/pubmed/35419669?tool=bestpractice.com
[51]Chung MK, Eckhardt LL, Chen LY, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association. Circulation. 2020 Apr 21;141(16):e750-72.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000748
http://www.ncbi.nlm.nih.gov/pubmed/32148086?tool=bestpractice.com
Atualmente as diretrizes dos EUA recomendam que os pacientes com aumento do risco de fibrilação atrial (FA) adotem uma modificação dos fatores de risco e do estilo de vida orientada por diretrizes, a qual inclui a manutenção do peso ideal e a perda de peso se eles tiverem sobrepeso ou obesidade, adoção de um estilo de vida fisicamente ativo, redução do consumo não saudável de bebidas alcoólicas, abandono do hábito de fumar, controle do diabetes e controle da pressão arterial/hipertensão.[1]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024 Jan 2;149(1):e1-156.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001193?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/38033089?tool=bestpractice.com
O uso de inibidores da ECA, estatinas e componentes lipídicos alimentares específicos presentes em determinados tipos de peixe demonstrou reduzir a incidência da FA.[70]Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9.
http://www.ncbi.nlm.nih.gov/pubmed/15936615?tool=bestpractice.com
[71]Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005 Mar 1;45(5):712-9.
http://www.ncbi.nlm.nih.gov/pubmed/15734615?tool=bestpractice.com
[72]Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006 May 16;47(10):1997-2004.
http://www.onlinejacc.org/content/47/10/1997
http://www.ncbi.nlm.nih.gov/pubmed/16697316?tool=bestpractice.com
[73]Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003 Dec 15;92(12):1379-83.
http://www.ncbi.nlm.nih.gov/pubmed/14675569?tool=bestpractice.com
[74]Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol. 2003 Dec 1;92(11):1343-5.
http://www.ncbi.nlm.nih.gov/pubmed/14636918?tool=bestpractice.com
[75]Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004 Jul 27;110(4):368-73.
http://circ.ahajournals.org/content/110/4/368.full
http://www.ncbi.nlm.nih.gov/pubmed/15262826?tool=bestpractice.com
O tratamento pré-operatório com um betabloqueador ou amiodarona reduz a incidência pós-operatória de FA em pacientes submetidos a cirurgias cardíacas ou com risco elevado de FA.[1]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024 Jan 2;149(1):e1-156.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001193?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/38033089?tool=bestpractice.com
[5]Paciaroni M, Agnelli G, Caso V, et al. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost. 2005 Jun;3(6):1218-23.
http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2005.01344.x/full
http://www.ncbi.nlm.nih.gov/pubmed/15892862?tool=bestpractice.com
[
]
What are the effects of pharmacological interventions to prevent atrial fibrillation after heart surgery?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.922/fullMostre-me a resposta
[
]
How does amiodarone compare with placebo for the prevention of sudden cardiac death in at-risk adults?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1289/fullMostre-me a resposta Intervenções não farmacológicas, inclusive a estimulação atrial, também podem ser consideradas para a prevenção da FA pós-operatória nos pacientes submetidos a cirurgias cardíacas.[76]Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003611.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003611.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/23440790?tool=bestpractice.com
[
]
What are the effects of non-pharmacological interventions to prevent atrial fibrillation after heart surgery?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.921/fullMostre-me a resposta
Em pacientes com apneia obstrutiva do sono, o manejo ideal da condição pode reduzir a incidência e a recorrência da FA.[1]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024 Jan 2;149(1):e1-156.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001193?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/38033089?tool=bestpractice.com
[2]Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021 Feb 1;42(5):373-498.
https://academic.oup.com/eurheartj/article/42/5/373/5899003
http://www.ncbi.nlm.nih.gov/pubmed/32860505?tool=bestpractice.com
A atividade física moderada pode prevenir o desenvolvimento de FA; no entanto, descobriu-se que a atividade extenuante pode aumentar o risco de FA.[3]Lévy S, Steinbeck G, Santini L, et al. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol. 2022 Oct;65(1):287-326.
http://www.ncbi.nlm.nih.gov/pubmed/35419669?tool=bestpractice.com
[77]Mishima RS, Verdicchio CV, Noubiap JJ, et al. Self-reported physical activity and atrial fibrillation risk: a systematic review and meta-analysis. Heart Rhythm. 2021 Apr;18(4):520-8.
https://www.heartrhythmjournal.com/article/S1547-5271(20)31165-6/abstract
http://www.ncbi.nlm.nih.gov/pubmed/33348059?tool=bestpractice.com
Pode ser apropriado recomendar cautela àqueles que realizam anos de treinamento regular de resistência de alto volume (≥3 horas/dia) e alta intensidade; existem dados observacionais que relacionam isso ao aumento do risco de FA em homens e um risco semelhante em curva J observado para atividade alta ou vigorosa em homens e mulheres em outro estudo.[1]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024 Jan 2;149(1):e1-156.
https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001193?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/38033089?tool=bestpractice.com
[78]Newman W, Parry-Williams G, Wiles J, et al. Risk of atrial fibrillation in athletes: a systematic review and meta-analysis. Br J Sports Med. 2021 Nov;55(21):1233-8.
https://bjsm.bmj.com/content/55/21/1233.long
http://www.ncbi.nlm.nih.gov/pubmed/34253538?tool=bestpractice.com
[79]Morseth B, Graff-Iversen S, Jacobsen BK, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study. Eur Heart J. 2016 Aug 1;37(29):2307-13.
https://academic.oup.com/eurheartj/article/37/29/2307/2237632?login=false
http://www.ncbi.nlm.nih.gov/pubmed/26966149?tool=bestpractice.com